Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added the study condition 'Gastric cancer' and a new resource link to the Genetic and Rare Diseases Information Center; Updated the page revision to v3.4.2, replacing v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T16:23:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. No substantive study-related content appears to have changed.
    Difference
    0.0%
    Check dated 2026-02-06T11:34:23.000Z thumbnail image
  4. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this is a minor page version update and does not affect the study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T11:27:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new revision label v3.3.4 was added and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:28:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Locations were updated with new sites across multiple countries and US states, and several existing locations were removed.
    Difference
    2%
    Check dated 2025-12-24T19:54:24.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the ClinicalTrials.gov page.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:10.000Z thumbnail image

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.